Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES PROCTER & GAMBLE HEALTH DIVIS LABORATORIES/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 29.2 34.6 84.3% View Chart
P/BV x 7.4 11.4 65.2% View Chart
Dividend Yield % 0.9 1.3 72.8%  

Financials

 DIVIS LABORATORIES   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
PROCTER & GAMBLE HEALTH
Jun-22
DIVIS LABORATORIES/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs5,4255,850 92.7%   
Low Rs3,5623,925 90.7%   
Sales per share (Unadj.) Rs337.5671.3 50.3%  
Earnings per share (Unadj.) Rs111.5116.0 96.2%  
Cash flow per share (Unadj.) Rs123.3132.3 93.2%  
Dividends per share (Unadj.) Rs30.0052.50 57.1%  
Avg Dividend yield %0.71.1 62.2%  
Book value per share (Unadj.) Rs441.8367.0 120.4%  
Shares outstanding (eoy) m265.4716.60 1,599.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.37.3 182.9%   
Avg P/E ratio x40.342.1 95.6%  
P/CF ratio (eoy) x36.536.9 98.7%  
Price / Book Value ratio x10.213.3 76.4%  
Dividend payout %26.945.3 59.4%   
Avg Mkt Cap Rs m1,192,89081,132 1,470.3%   
No. of employees `000NANA-   
Total wages/salary Rs m9,4621,676 564.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,59811,144 804.0%  
Other income Rs m1,159132 878.7%   
Total revenues Rs m90,75711,276 804.9%   
Gross profit Rs m38,8112,677 1,449.9%  
Depreciation Rs m3,115271 1,150.3%   
Interest Rs m204 476.2%   
Profit before tax Rs m36,8352,534 1,453.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,231609 1,188.2%   
Profit after tax Rs m29,6051,925 1,537.7%  
Gross profit margin %43.324.0 180.3%  
Effective tax rate %19.624.0 81.7%   
Net profit margin %33.017.3 191.3%  
BALANCE SHEET DATA
Current assets Rs m96,1049,895 971.3%   
Current liabilities Rs m24,5446,117 401.3%   
Net working cap to sales %79.933.9 235.6%  
Current ratio x3.91.6 242.0%  
Inventory Days Days9263 3.3%  
Debtors Days Days987273 361.3%  
Net fixed assets Rs m50,0879,540 525.0%   
Share capital Rs m531166 319.8%   
"Free" reserves Rs m116,7515,926 1,970.1%   
Net worth Rs m117,2826,092 1,925.1%   
Long term debt Rs m00-   
Total assets Rs m146,19119,435 752.2%  
Interest coverage x1,842.8604.3 305.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.6 106.9%   
Return on assets %20.39.9 204.1%  
Return on equity %25.231.6 79.9%  
Return on capital %31.441.7 75.4%  
Exports to sales %00-   
Imports to sales %19.711.3 174.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,6761,263 1,399.7%   
Fx inflow Rs m78,4451,226 6,398.0%   
Fx outflow Rs m17,9531,263 1,421.7%   
Net fx Rs m60,492-37 -164,828.1%   
CASH FLOW
From Operations Rs m19,1181,695 1,127.8%  
From Investments Rs m-21,949-255 8,594.0%  
From Financial Activity Rs m-5,324-2,886 184.5%  
Net Cashflow Rs m-8,156-1,447 563.8%  

Share Holding

Indian Promoters % 51.9 0.0 -  
Foreign collaborators % 0.0 51.9 -  
Indian inst/Mut Fund % 36.2 18.7 193.8%  
FIIs % 15.4 6.1 254.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 48.2 99.8%  
Shareholders   379,257 65,148 582.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Divis Laboratories vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Procter & Gamble Health Share Price Performance

Period Divis Laboratories Procter & Gamble Health S&P BSE HEALTHCARE
1-Day -1.45% 0.69% -0.89%
1-Month -0.29% -0.67% -1.85%
1-Year -28.60% -21.58% -6.83%
3-Year CAGR 22.11% -0.59% 20.56%
5-Year CAGR 25.57% 30.10% 10.73%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Procter & Gamble Health the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Procter & Gamble Health paid Rs 52.5, and its dividend payout ratio stood at 45.3%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

NTPC to Build Nuclear Fleet | Inox Group's Big Fundraise to Pare Debt | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets extended gains during the last hour of trade to end higher.